MAG
WST icon

Mass Ave Global’s West Pharmaceutical WST Stock Holding History

Mass Ave Global’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.37M Buy
+5,833
New +$1.38M 0.4% 29

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mass Ave Global's WST Position: Q4 2022 in Review

Mass Ave Global opened a new position in West Pharmaceutical (WST) in Q4 2022: 5,833 shares worth $1.37M. The stake represents 0.4% of the portfolio and ranks #29 among its holdings.

637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Mass Ave Global held 5,833 shares of West Pharmaceutical worth $1.37M as of Q4 2022.
  • West Pharmaceutical was a new Mass Ave Global position in Q4 2022.
  • West Pharmaceutical made up 0.4% of Mass Ave Global's portfolio in Q4 2022, its #29 holding.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Mass Ave Global's 13F filing for Q4 2022, filed 14 Feb 2023.